Exchange: NASDAQ·Updated 12:43 PM EDT
MNPR logo

MNPR Monopar Therapeutics Inc

$109.95
$1.94
(1.73%)
Today
Reported EarningsAug 12
Mkt Cap$751.02M
Vol74,094.00

About MNPR

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
51

Neutral Sentiment

How do you feel about MNPR?

Advertisement|Remove ads.